Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis

Detalles Bibliográficos
Autores principales: D’Alessandro, Roberto, Garcia Gonzalez, Estrella, Frediani, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Letter to the Editor (Case report)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053684/
https://www.ncbi.nlm.nih.gov/pubmed/33898920
http://dx.doi.org/10.1093/rap/rkab023
_version_ 1783680168452161536
author D’Alessandro, Roberto
Garcia Gonzalez, Estrella
Frediani, Bruno
author_facet D’Alessandro, Roberto
Garcia Gonzalez, Estrella
Frediani, Bruno
author_sort D’Alessandro, Roberto
collection PubMed
description
format Online
Article
Text
id pubmed-8053684
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80536842021-04-22 Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis D’Alessandro, Roberto Garcia Gonzalez, Estrella Frediani, Bruno Rheumatol Adv Pract Letter to the Editor (Case report) Oxford University Press 2021-04-17 /pmc/articles/PMC8053684/ /pubmed/33898920 http://dx.doi.org/10.1093/rap/rkab023 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor (Case report)
D’Alessandro, Roberto
Garcia Gonzalez, Estrella
Frediani, Bruno
Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
title Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
title_full Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
title_fullStr Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
title_full_unstemmed Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
title_short Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
title_sort efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
topic Letter to the Editor (Case report)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053684/
https://www.ncbi.nlm.nih.gov/pubmed/33898920
http://dx.doi.org/10.1093/rap/rkab023
work_keys_str_mv AT dalessandroroberto efficacyofbelimumabmonotherapyinhighinfectiousriskpatientaffectedbylupusnephritis
AT garciagonzalezestrella efficacyofbelimumabmonotherapyinhighinfectiousriskpatientaffectedbylupusnephritis
AT fredianibruno efficacyofbelimumabmonotherapyinhighinfectiousriskpatientaffectedbylupusnephritis

Ejemplares similares